Save time and get answers to complex questions with AI chat
Somatuline depot patent expiry date?How long have hydroxyzine pamoate been on the market?When will there be a generic loreev available?Dabrafenib mesylate when the patent is expiring in india?Defense strategy against generic in niche market?
See the DrugPatentWatch profile for Tagrisso
Tagrisso is the brand name for the small‑molecule epidermal growth factor receptor (EGFR) inhibitor osimertinib. Below is a quick “molecule‑level” snapshot of osimertinib: | Property | Value | |----------|-------| | IUPAC name | 5‑(4‑(2‑(morpholin‑4‑yl)ethyl)phenyl)-2‑(3‑(4‑(2‑(morpholin‑4‑yl)ethyl)phenyl)amino)quinazolin‑4‑yl‑3‑(1H‑1,2,4‑triazol‑3‑yl)ethanone | | Molecular formula | C₂₂H₂₃N₅O | | SMILES | CC1=CN(C)C2=NC(=O)N=C2N1C3=CC=CC=C3C4=C2N=CC=C4O | | InChI | `1S/C22H23N5O/c1-15-3-4-16(5-15)17-9-11-18(24)20-12-6-7-13-22(20)25-21(18)23-19(2)14-10-8-19/h3-5,9-14,17H,6-8,15-16H2,
CC1=CN(C)C2=NC(=O)N=C2N1C3=CC=CC=C3C4=C2N=CC=C4O
Other Questions About Tagrisso :